Michael Janssen
Family Medicine · Jacksonville, FLNPI 1942272356
Payments from drug & device makers
Across 147 payments — averaging $25.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$721
- Lilly USA, LLC$676
- AbbVie$581
- Novo Nordisk$510
- GSK$328
- Amgen$241
- plus $717 from 18 others
What the payments were for
- Food & beverage$3,775100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 20 | $721 |
| Lilly USA, LLC | 24 | $676 |
| AbbVie(2 entities) | 23 | $581 |
| Novo Nordisk | 24 | $510 |
| GSK | 13 | $328 |
| Amgen(2 entities) | 4 | $241 |
| Pfizer | 9 | $217 |
| Boehringer Ingelheim | 5 | $76 |
| Amarin Pharma, Inc. | 4 | $72 |
| Teva Pharmaceuticals USA, Inc. | 5 | $61 |
| Scilex Pharmaceuticals Inc. | 1 | $47 |
| Genentech USA, Inc. | 2 | $36 |
| Sanofi-aventis U.S. LLC | 2 | $32 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $31 |
| Bayer | 1 | $17 |
| Insulet Corporation | 1 | $17 |
| BD | 1 | $15 |
| Novartis | 1 | $15 |
| Kowa Pharmaceuticals America, Inc. | 1 | $15 |
| Merck | 1 | $15 |
| Upsher-smith Laboratories LLC | 1 | $13 |
| Astellas Pharma US Inc | 1 | $13 |
| Idorsia Pharmaceuticals US Inc | 1 | $13 |
| Cranial Technologies, Inc | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,775 in reported general payments places this provider in the 80th percentile of 7,282 family medicine providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Duloxetine Hcl | 14 | $1,558 |
| Rosuvastatin Calcium | 44 | $701 |
| Terazosin Hcl | 38 | $514 |
| Levothyroxine Sodium | 47 | $497 |
| Atorvastatin Calcium | 43 | $461 |
| Lansoprazole | 14 | $350 |
| Metoprolol Succinate | 18 | $349 |
| Omeprazole | 29 | $328 |
| Amlodipine Besylate | 46 | $324 |
| Simvastatin | 40 | $294 |
| Lisinopril | 41 | $292 |
| Ezetimibe | 14 | $287 |
| Gabapentin | 17 | $251 |
| Carvedilol | 28 | $249 |
| Allopurinol | 33 | $229 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Jacksonville
- Jeffry JacqmeinJacksonville$8.7M
- Herman DowneyJacksonville$4.1M
- Hugh ColemanDaytona Beach$115.5M
- Alexander WhiteDaytona Beach$69.7M
- Ronald SurowitzJupiter$38.3M
- Bruce RankinDeland$36.7M
- Keila HooverMiami$33.7M
- John NardandreaOcala$30.8M
- Jorge CasoMiami$22.6M
- Sharrell CooperPalm Coast$16.9M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.